Study of Mometasone Furoate/Formoterol Fumarate (MF/F) Metered Dose Inhaler (MDI) in Adolescents & Adults With Persistent Asthma (P08212)

Exclusion Criteria

• •Treatment in the emergency room (for a severe asthma exacerbation), or admitted to the hospital for management of airway obstruction within previous 3 months
• •Any prior ventilator support for respiratory failure secondary to asthma,
• •Upper or lower respiratory tract infection (viral or bacterial) within previous 2 weeks
• •History of a medical condition that, in the investigator's opinion, may interfere with study participation,
• •History of smoking within previous year or a cumulative smoking history of more than 10 pack-years
• •Known allergy to or intolerance of ICSs, LABAs, or any of the ingredients included in the study medications
• •History of use of illicit drugs
• •Inability to correctly use an oral MDI
• •Pregnant, breastfeeding or plans to become pregnant during study